EP300 and cancer: For example, the ratios of M1/M2 macrophages were significantly higher in EP300-mutated than those in EP300-wild-type cancers in BLCA, HNSC, CESC, STAD, and ESCA; the permutation test showed that this finding was significant (p < 0.0001).